Wegovy woes continue as manufacturing issues will lead to further shortage of Novo's obesity drug
As the new year rapidly approaches, and gyms and health food stores across America prepare for a wave of people seeking weight loss, Novo Nordisk …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
